AMC Robotics Corp 10-Q

ITEM 1. FINANCIAL STATEMENTS. ALPHAVEST ACQUISITION CORP CONSOLIDATED BALANCE SHEETS September 30, 2025 December 31, 2024 (Unaudited) ASSETS Current Assets: Cash $ 3,713 $ 4,215 Prepaid expenses 22,175 3,789 Total Current Assets 25,888 8,004 Marketable securities held in trust account - 18,000,701 Cash held in trust escrow account 18,929,689 55,000 Total Assets $ 18,955,577 $ 18,063,705 LIABILITIES, REDEEMABLE ORDINARY SHARES, AND SHAREHOLDERS’ DEFICIT Current Liabilities: Accounts payable and accrued expenses $ 903,092 $ 488,308 Accrued underwriting discount 2,415,000 - Other payable 70,000 125,000 Due to related party 45,968 9,837 Promissory notes – related party 558,326 507,046 Promissory notes – third party 1,272,411 623,449 Promissory notes 1,272,411 623,449 Total Current Liabilities 5,264,797 1,753,640 Total Liabilities 5,264,797 1,753,640 Commitments and contingencies - - Ordinary shares subject to possible redemption ( 1,574,356 shares at $ 12.02 and $ 11.47 per share as of September 30, 2025 and December 31, 2024, respectively) 18,929,689 18,055,701 Shareholders’ Deficit: Preferred shares, $ 0.0001 par value; 2,000,000 shares authorized; none issued and outstanding as of September 30, 2025 and December 31, 2024, respectively - - Ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; 2,280,500 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 228 228 Additional paid-in capital - - Accumulated deficit ( 5,239,137 ) ( 1,745,864 ) Total Shareholders’ Deficit ( 5,238,909 ) ( 1,745,636 ) T otal Liabilities, Redeemable Ordinary Shares, and Shareholders’ Deficit $ 18,955,577 $ 18,063,705 The accompanying notes are an integral part of the unaudited consolidated financial statements. 1 ALPHAVEST ACQUISITION CORP CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) 2025 2024 2025 2024 Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Formation and operating costs $ 2,816,519 $ 182,580 $ 3,163,276 $ 566,903 Loss from operations ( 2,816,519 ) ( 182,580 ) ( 3,163,276 ) ( 566,903 ) Other Income (expenses): Interest income on investments held in trust account 165,168 684,600 543,988 1,893,221 Unrealized loss on investments held in trust account - - - ( 92,316 ) Bank interest income 1 1 2 6 Total other income 165,169 684,601 543,990 1,800,911 Net income (loss) $ ( 2,651,350 ) $ 502,021 $ ( 2,619,286 ) $ 1,234,008 Weighted average common stock outstanding, common stock subject to possible redemption 1,574,356 4,725,829 1,574,356 4,725,829 Basic and diluted net income (loss) per share, common stock subject to redemption $ ( 0.63 ) $ 0.13 $ ( 0.33 ) $ 0.33 Weighted average common stock outstanding, common stock, non-redeemable 2,280,500 2,280,500 2,280,500 2,280,500 Basic and diluted net loss per share, common stock, non-redeemable $ ( 0.73 ) $ ( 0.06 ) $ ( 0.92 ) $ ( 0.14 ) The accompanying notes are an integral part of the unaudited consolidated financial statements. 2 ALPHAVEST ACQUISITION CORP CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT (UNAUDITED) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 Ordinary shares Amount Additional paid-in capital Accumulated deficit Total shareholders’ deficit Balance as of January 1, 2025 2,280,500 $ 228 $ - ( 1,745,864 ) ( 1,745,636 ) Accretion for ordinary shares subject to redemption amount (interest income) - - - ( 187,179 ) ( 187,179 ) Accretion for ordinary shares subject to redemption amount (extension deposit) - - - ( 165,000 ) ( 165,000 ) Net income - - - 8,697 8,697 Balance as of March 31, 2025 2,280,500 $ 228 $ - $ ( 2,089,346 ) $ ( 2,089,118 ) Accretion for ordinary shares subject to redemption amount (interest income) - - - ( 191,641 ) ( 191,641 ) Accretion for ordinary shares subject to redemption amount (extension deposit) - - - ( 165,000 ) ( 165,000 ) Net income - - - 23,368 23,368 Balance as of June 30, 2025 2,280,500 $ 228 $ - $ ( 2,422,619 ) $ ( 2,422,391 ) Accretion for ordinary shares subject to redemption amount (interest income) - - - ( 165,168 ) ( 165,168 ) Net loss - - - ( 2,651,350 ) ( 2,651,350 ) Balance as of September 30, 2025 2,280,500 $ 228 $ - $ ( 5,239,137 ) $ ( 5,238,909 ) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 Ordinary shares Amount Additional paid-in capital Accumulated deficit Total shareholders’ deficit Balance as of January 1, 2024 2,280,500 $ 228 $ - $ ( 325,050 ) $ ( 324,822 ) Accretion for ordinary shares subject to redemption amount (interest income) - - - ( 586,164 ) ( 586,164 ) Accretion for ordinary shares subject to redemption amount (extension deposit) - - - ( 55,000 ) ( 55,000 ) Net income - - - 349,241 349,241 Balance as of March 31, 2024 2,280,500 $ 228 $ - $ ( 616,973 ) $ ( 616,745 ) Accretion for ordinary shares subject to redemption amount (interest income) - - - ( 530,141 ) ( 530,141 ) Accretion for ordinary shares subject to redemption amount (extension deposit) - - - ( 110,000 ) ( 110,000 ) Net income - - - 382,746 382,746 Balance as of June 30, 2024 2,280,500 $ 228 $ - $ ( 874,368 ) $ ( 874,140 ) Balance 2,280,500 $ 228 $ - $ ( 874,368 ) $ ( 874,140 ) Accretion for ordinary shares subject to redemption amount (interest income) - - - ( 684,600 ) ( 684,600 ) Accretion for ordinary shares subject to redemption amount (extension deposit) - - - ( 220,000 ) ( 220,000 ) Net income - - - 502,021 502,021 Net income (loss) - - - 502,021 502,021 Balance as of September 30, 2024 2,280,500 $ 228 $ - $ ( 1,276,947 ) $ ( 1,276,719 ) Balance 2,280,500 $ 228 $ - $ ( 1,276,947 ) $ ( 1,276,719 ) The accompanying notes are an integral part of the unaudited consolidated financial statements. 3 ALPHAVEST ACQUISITION CORP CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) 2025 2024 Nine Months Ended September 30, 2025 2024 Cash flows from operating activities: Net (loss) income $ ( 2,619,286 ) 1,234,008 Adjustments to reconcile net (loss) income to net cash used in operating activities: Trust investment income ( 543,988 ) ( 1,893,221 ) Unrealized loss on investments held in trust account - 92,316 Changes in operating assets and liabilities: Prepaid expense 80,598 94,175 Accounts payable and accrued offering costs and expenses 631,043 366,677 Accrued underwriting discount 2,415,000 - Promissory note – related party - 14,580 Other payable - 70,000 Due to related party 36,131 - Net cash used in operating activities ( 502 ) ( 21,465 ) Cash flows from investing activities: Cash deposited to trust account ( 385,000 ) ( 330,000 ) Cash deposited to trust escrow account - ( 55,000 ) Net cash used in investing activities ( 385,000 ) ( 385,000 ) Cash flows from financing activities: Proceeds from promissory note - related party - 55,000 Proceeds from promissory note - third party 385,000 330,000 Net cash provided by financing activities 385,000 385,000 Net change in cash ( 502 ) ( 21,465 ) Cash at beginning of period 4,215 28,560 Cash at end of period $ 3,713 7,095 Supplemental disclosure of noncash investing and financing activities Accretion for ordinary shares subject to redemption amount $ 873,988 $ 2,185,905 Accrued expenses converted to promissory note – related party $ 52,000 $ 188,587 Accrued expenses converted to promissory note – third party $ 164,978 $ 45,000 Other payable converted to promissory note – third party $ 55,000 $ - Prepaid expenses paid by promissory note – third party $ 98,984 $ 81,000 Cash in trust account transferred to trust escrow account for closing $ 18,929,689 $ - The accompanying notes are an integral part of the unaudited consolidated financial statements. 4 ALPHAVEST ACQUISITION CORP NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 — ORGANIZATION AND BUSINESS OPERATIONS AlphaVest Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on January 14, 2022. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2025, the Company had not commenced any operations. All activity through September 30, 2025 relates to the Company’s formation and the initial public offering (“IPO”) and initial business combination, which is described below. The Company will not generate any operating revenues until after the completion an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s IPO (the “Registration Statement”) was declared effective on December 19, 2022. On December 22, 2022, the Company consummated the IPO of 6,000,000 units, (“Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”), generating gross proceeds of $ 60,000,000 , which is described in Note 3, and the sale of 390,000 Units (the “Private Placement Units”) at a price of $ 10.00 per Private Placement Unit in private placements to AlphaVest Holding LP (the “Sponsor”) that was closed simultaneously with the IPO. Following the closing of the IPO on December 22, 2022, an amount of $ 61,200,000 ($ 10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement (as defined in Note 4) was placed in the trust account. The funds held in the trust account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the trust account, as described below. On December 29, 2022, EarlyBirdCapital, Inc. (“EBC”) fully exercised their over-allotment option, resulting in an additional 900,000 Units issued for an aggregate amount of $ 9,000,000 . In connection with EBC’s full exercise of their over-allotment option, the Company also consummated the sale of an additional 40,500 Private Units at $ 10.00 per Private Unit, generating total proceeds of $ 405,000 . The Company will have until the last Extended Date, January 22, 2026 to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100 % of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned and not previously released to us to pay our taxes, if any (less up to $ 100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Extension On December 21, 2023, the Company held a special meeting of shareholders, at which the Company’s shareholders approved (i) an amendment to the Company’s amended and restated certificate of incorporation (the “Extension Amendment”) and (ii) an amendment (the “Trust Agreement Amendment”) to the Investment Management Trust Agreement, dated December 19, 2022, with Continental Stock Transfer & Trust Company. Pursuant to the Trust Agreement Amendment, the Company has extended the date by which it has to complete a business combination from December 22, 2023 (the “Termination Date”) up to 10 times, with the first extension comprised of three months, and the subsequent 9 extensions comprised of one month each from the Termination Date, or extended date, as applicable, to December 22, 2024. In connection with the shareholders’ vote at the special meeting, an aggregate of 2,174,171 shares with redemption value of approximately $ 23,282,936 (approximately $ 10.71 per share) of the Company’s ordinary shares were tendered for redemption. 5 On December 18, 2024, the Company held another extraordinary general meeting (the “ 2024 Extraordinary General Meeting ”) at which the shareholders of the Company voted on three proposals: (i) a proposal, by special resolution, to amend the Company’s Second Amended and Restated Memorandum and Articles of Association to (a) extend the date by which the Company must consummate a business combination up to nine (9) times from December 22, 2024 to September 22, 2025 (the “ Revised Termination Date ”), each by an additional one (1) month, for a total of up to nine (9) months, assuming a business combination has not occurred, and (b) delete the provision (the “ Redemption Limitation ”) that the Company shall not redeem public shares to the extent that such redemption would cause the Company’s net tangible assets to be less than $ 5,000,001 ; (ii) a proposal, by ordinary resolution, to further amend the Trust Agreement to effectuate the foregoing extension and depositing into the Trust Account $ 55,000 per one-month extension two (2) days prior to such extension (assuming a business combination has not occurred) in exchange for a non-interest bearing, unsecured promissory note payable upon the consummation of a business combination; and (iii) a proposal, by ordinary resolution, to adjourn the 2024 Extraordinary General Meeting, to a later date or dates, if necessary. In connection with the shareholders’ vote at the 2024 Extraordinary General Meeting, shareholders of 3,151,473 ordinary shares of the Company exercised their right to redeem such shares (the “ 2024 Redemption ”) for a pro rata portion of the funds held in the Trust Account. As a result, approximately $ 35,956,676 (approximately $ 11.41 per share) was removed from the Trust Account to pay such holders and approximately $ 17,962,587 remained in the Trust Account. Following the 2024 Redemptions, the Company had 3,854,856 ordinary shares outstanding. On September 19, 2025, the Company held another extraordinary general meeting (the “2025 Extension Meeting”) to approve a proposal to extend the time the Company had to consummate its initial Business Combination from September 22, 2025 up to four (4) times, to January 22, 2026, and deposit into the trust account $ 55,000 for each monthly extension. The Company filed a supplement to its proxy statement which clarified certain procedures related to shareholders wishing to redeem their ordinary shares in connection with the 2025 Extension Meeting and/or the Company’s business combination. See below “Proposed Business Combination” for redemption details. On December 21, 2023, the Company issued a promissory note to Alphavest Holding LP, one of the Sponsors, pursuant to which the Company could borrow an aggregate of $ 165,000 (the “Extension Note”) to cover expenses in connection with the extension of Business Combination Period. Principal of this Extension Note may be drawn down from time to time prior to the Maturity Date upon written request from the Company. On April 15, 2024, the Company amended and restated the Extension Note to increase the principal amount to $ 715,000 and extend the maturity date to the earlier of : (i) September 12, 2024 or (ii) promptly after the date of the consummation of the business combination. On October 25, 2024, the Extension Note was further amended and restated to extend the maturity date to promptly after the date the business combination is consummated. On May 2, 2024, the Company issued a promissory note to a potential target, pursuant to which the Company could borrow an aggregate of $ 440,000 (the “Extension Note 2”) to cover expenses in connection with the extension of Business Combination Period. Principal of this Extension Note 2 may be drawn down from time to time prior to the Maturity Date upon written request from the Company. On January 6, 2025, the promissory note was amended and restated to extend the maturity date to promptly after the date the business combination is consummated. On March 25, 2025, the promissory note was further amended to increase the principal amount to $ 935,000 . As of November 19, 2025, an aggregate of $ 1,265,000 was deposited into trust account and trust escrow account, to extend the business combination period to November 22, 2025. Proposed Business Combination On August 11, 2023, the Company (at and after the Merger Effective Date, “PubCo”) entered into a business combination agreement (the “Business Combination Agreement”) with AV Merger Sub, a Cayman Islands exempted company and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Wanshun Technology Industrial Group Limited, a Cayman Islands exempted company (“Wanshun”). On March 18, 2024, the Company delivered to Wanshun a Notice of Termination of Business Combination (the “Termination”), in which the Business Combination Agreement was terminated pursuant to Section 8.1(e) of the Business Combination Agreement. The termination of the Business Combination Agreement is effective as of March 18, 2024. For additional information regarding the Transactions, the Business Combination Agreement, Notice of Termination of Business Combination and Wanshun, see the most recent Annual Report on Form 10-K and Current Reports on Form 8-K filed by the Company with the SEC on August 14, 2023, August 17, 2023 and March 25, 2024. 6 On May 2, 2024, the Company issued a promissory note to AMC (defined below) (the “Extension Note 2”), pursuant to which the Company could borrow an aggregate of $ 440,000 to cover expenses in connection with the extension of Business Combination Period. The Extension Note 2 bears no interest. The entire unpaid principal balance of this Note shall be payable on the earlier of: (i) December 12, 2024 or (ii) promptly after the date on which Maker consummates an initial business combination. Upon receiving due notification by the Company of the closing of a business combination, AMC shall convert the unpaid principal balance under Extension Note 2 into a number of shares of non-transferable, non-redeemable, ordinary shares of the Company equal to: (x) the principal amount of this Extension Note 2 being converted, divided by (y) the conversion price of Ten Dollars ($ 10.00 ), rounded up to the nearest whole number of shares, with such conversion to be effective immediately prior to the closing the such business combination. On January 6, 2025, the promissory note was amended and restated to extend the maturity date to promptly after the date the business combination is consummated. On March 25, 2025, the promissory note was further amended to increase the principal amount to $ 935,000 . As of September 30, 2025 and December 31, 2024, $ 825,000 and $ 440,000 were outstanding, respectively. On May 2, 2024, the Company issued a promissory note to AMC (the “Promissory Note 2”), pursuant to which the Company could borrow up to an aggregate of $ 126,000 . The Promissory Note 2 bears no interest. The entire unpaid principal balance of this Promissory Note 2 shall be payable on the earlier of: (i) December 12, 2024 or (ii) promptly after the date on which Maker consummates an initial business combination. Upon receiving due notification by the Company of the closing of a business combination, AMC shall convert the unpaid principal balance under Promissory Note 2 into a number of shares of non-transferable, non-redeemable, ordinary shares of the Company equal to: (x) the principal amount of this Promissory Note 2 being converted, divided by (y) the conversion price of Ten Dollars ($ 10.00 ), rounded up to the nearest whole number of shares, with such conversion to be effective immediately prior to the closing the such business combination. On January 6, 2025, the promissory note was amended and restated to extend the maturity date to promptly after the date the business combination is consummated. As of September 30, 2025 and December 31, 2024, $ 126,000 was outstanding. On August 16, 2024, the Company entered into a business combination agreement (the “Merger Agreement”) with AV Merger Sub, wholly owned subsidiary of the Company (“Merger Sub”), and AMC Corporation, a Washington corporation (“AMC”). Upon the terms and subject to the conditions of the Merger Agreement, and in accordance with applicable law, Merger Sub will merge with AMC, with AMC surviving the merger as a wholly owned subsidiary of the Company. On June 25, 2025, the Company entered into an Amendment to the Merger Agreement, to (i) increase the enterprise value from $ 175,000,000 to $ 180,000,000 and (ii) extend the termination date of the Merger Agreement to December 31, 2025. On October 11, 2024, the Company issued a third non-interest-bearing promissory note to AMC (the “Promissory 3”) pursuant to which the Company could borrow up to an aggregate of $ 100,000 to cover the Company’s working capital requirements. The promissory note is due and payable on the earlier of: (i) December 31, 2024, or (ii) promptly after the date on which the business combination is consummated. On January 6, 2025, the promissory note was amended and restated to (i) extend the maturity date to promptly after the date the business combination is consummated, and (ii) increase the principal amount to $ 200,000 . On April 13, 2025, the Company further amended and restated the promissory note to extend the principal amount of the note to $ 350,000 . As of September 30, 2025 and December 31, 2024, $ 321,411 and $ 57,449 were outstanding. The Company’s Registration Statement on Form S-4 (“S-4”) was declared effective on August 11, 2025. As of the filing date, the business combination remained pending, awaiting required regulatory approvals. On September 5, 2025, the Company held an extraordinary general meeting to approve the business combination with AMC (the “Business Combination Meeting). At the meeting, all proposals were approved by shareholders. In connection with the shareholders’ vote at the 2025 Extension Meeting, 1,937 ordinary shares of the Company exercised their right to redeem such shares for a pro rata portion of the funds held in the Trust Account. In connection with the Business Combination Meeting, shareholders holding an aggregate of 214,445 Ordinary Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Shareholders holding 631,972 ordinary shares of the Company exercised their right to redeem such shares for a pro rata portion of the funds held in the trust account in connection with both the 2025 Extension Meeting and the Business Combination Meeting, for a total of 848,354 ordinary shares submitted their shares for Redemption. Following the aforementioned redemptions, the Company will have 3,006,502 ordinary shares outstanding. 7 Going Concern Consideration and Management Liquidity Plans As of September 30, 2025, the Company had cash of $ 3,713 and working capital deficit of $ 5,238,909 . Subsequent to the consummation of the IPO, the Company expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. The Company expects that it will need additional capital to satisfy its needs for paying these costs. Although certain of the Company’s initial shareholders or their affiliates may loan the Company funds, there’s no guarantee that the Company will receive such funds. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that the Company will not have sufficient working capital to meet its needs through the earlier of the consummation of the initial Business Combination or one year from the issuance date of this financial statements. There is no assurance that the Company’s plan to consummate a business combination will be successful. If a Business Combination is not consummated by the relevant period, there will be a mandatory liquidation and subsequent dissolution. As a result, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued or are available to be issued. The consolidated financial statement does not include any adjustments that might result from the outcome of the uncertainty. NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the requirements of the U.S. Securities and Exchange Commission (“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted and should be read in conjunction with the Company’s latest annual financial statements. These unaudited consolidated financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2025, or for any other interim period or for any other future year. Principles of Consolidation The unaudited consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated upon consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. 8 Use of Estimates The preparation of the unaudited consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash balance of $ 3,713 and $ 4,215 as of September 30, 2025 and December 31, 2024, respectively. Investments Held in Trust Account The Company’s portfolio of investments held in the trust account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the trust account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in trust account are included in interest earned on marketable securities held in trust account in the accompanying statements of operations. The estimated fair value of investments held in the trust account is determined using available market information. As of September 30, 2025 and December 31, 2024, the trust escrow account and trust account had balance of $ 18,929,689 and $ 18,000,701 , respectively. The interest earned from the trust account totaled $ 165,168 and $ 684,600 for three months ended September 30, 2025 and 2024, respectively, and $ 543,988 and $ 1,800,905 for nine months ended September 30, 2025 and 2024, respectively. Prior to September 2025, funds held in trust account were fully reinvested into the trust account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statement of Cash Flows. In September 2025, the Company transferred the funds from the trust account to trust escrow account in connection with the upcoming business combination closing, at which point the funds ceased to be invested and no longer generate gain on investment. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “ Income Taxes .” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2025 and December 31, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. 9 There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statement. Net Income (Loss) per Ordinary Shares The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The consolidated statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of September 30, 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented. The net income (loss) per share presented in the statements of operations is based on the following: SCHEDULE OF NET INCOME (LOSS) PER SHARE 2025 2024 2025 2024 Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net income (loss) $ ( 2,651,350 ) $ 502,021 $ ( 2,619,286 ) $ 1,234,008 Accretion of temporary equity into redemption value (interest earned) ( 165,168 ) ( 684,600 ) ( 543,988 ) ( 1,800,904 ) Accretion of temporary equity into redemption value (extension deposit) - ( 220,000 ) ( 385,000 ) ( 385,000 ) Net loss including accretion of equity into redemption value $ ( 2,816,518 ) $ ( 402,579 ) $ ( 3,548,274 ) $ ( 951,896 ) Particulars Shares Shares Shares Shares Shares Shares Shares Shares For Three Months Ended September 30, 2025 For Nine Months Ended September 30, 2025 For Three Months Ended September 30, 2024 For Nine Months Ended September 30, 2024 Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Redeemable Non-Redeemable Particulars Shares Shares Shares Shares Shares Shares Shares Shares Basic and diluted net income (loss) per share: Weighted-average shares outstanding 1,574,356 2,280,500 1,574,356 2,280,500 4,725,829 2,280,500 4,725,829 2,280,500 Ownership percentage 41 % 59 % 41 % 59 % 67 % 33 % 67 % 33 % Numerators: Allocation of net loss including accretion of temporary equity ( 1,150,290 ) ( 1,666,228 ) ( 1,449,145 ) ( 2,099,129 ) ( 271,543 ) ( 131,036 ) ( 642,062 ) ( 309,834 ) Interest earned on investment held in trust account 165,168 - 543,988 - 684,600 - 1,800,904 - Accretion of temporary equity into redemption value (extension deposit) - - 385,000 - 220,000 - 385,000 - Allocation of net income (loss) ( 985,122 ) ( 1,666,228 ) ( 520,157 ) ( 2,099,129 ) 633,057 ( 131,036 ) 1,543,842 ( 309,834 ) Denominators: Weighted-average shares outstanding 1,574,356 2,280,500 1,574,356 2,280,500 4,725,829 2,280,500 4,725,829 2,280,500 Basic and diluted net income (loss) per share $ ( 0.63 ) $ ( 0.73 ) $ ( 0.33 ) $ ( 0.92 ) $ 0.13 $ ( 0.06 ) $ 0.33 $ ( 0.14 ) 10 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $ 250,000 . The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “ Fair Value Measurement ,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity ”. Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares is classified as stockholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2025 and December 31, 2024 , the ordinary shares subject to possible redemption in the amount of $ 18,929,689 and $ 18,000,701 , respectively, are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. At September 30, 2025, the ordinary shares reflected in the balance sheets are reconciled in the following table: SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION Ordinary shares subject to possible redemption at December 31, 2024 $ 18,055,701 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 187,179 Accretion for ordinary shares subject to redemption (extension deposit) 165,000 Ordinary shares subject to possible redemption at March 31, 2025 18,407,880 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 191,641 Accretion for ordinary shares subject to redemption (extension deposit) 165,000 Ordinary shares subject to possible redemption at June 30, 2025 18,764,521 Plus: Accretion for ordinary shares subject to redemption (income earned on investment held in trust account) 165,168 Ordinary shares subject to possible redemption at September 30, 2025 $ 18,929,689 Convertible Promissory Note The Company adopted the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) and accounts for its convertible promissory notes as debt (liability) on the balance sheet. The Company’s assessment of the embedded conversion feature (see Note 1 - Organization and Business Operations) considers the derivative scope exception guidance under ASC 815 pertaining to equity classification of contracts in an entity’s own equity. The conversion feature of these promissory notes meets the definition of a derivative instrument. However, bifurcation of conversion feature from the debt host is not required because the conversion feature meets ASC 815 scope exception, as the promissory notes are convertible in shares of the Company’s common stock which is considered indexed to the Company’s own stock and classified in stockholders’ equity. Recent Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. This was effective for the Company during three and nine months ended September 30, 2025, and did not have a material impact to the financial statements. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. 11 NOTE 3 — INITIAL PUBLIC OFFERING Pursuant to the IPO, the Company sold 6,000,000 Units at a price of $ 10.00 per Unit. Each Unit consists of one share of ordinary shares and one right to receive one-tenth (1/10) of one Ordinary shares upon the consummation of the Company’s initial business combination one right (“Public Right”) . Ten Public Rights will entitle the holder to one share of ordinary shares (see Note 6). We will not issue fractional shares and only whole shares will trade, so unless you purchase units in multiple of tens, you will not be able to receive or trade the fractional shares underlying the rights. On December 29, 2022, EBC fully exercised their over-allotment option, resulting in an additional 900,000 Units issued for an aggregate amount of $ 9,000,000 . See Note 1 for further details. NOTE 4 — RELATED PARTIES On February 7, 2022, the sponsor received 1,725,000 of the Company’s ordinary shares in exchange for $ 25,000 paid for deferred offering costs borne by the founder. Up to 225,000 of such founder shares are subject to forfeiture to the extent that EBC’s over-allotment is not exercised in full. As a result of EBC’s election to fully exercise their over-allotment option on December 29, 2022, no founder shares are currently subject to forfeiture. On April 18, 2023, AlphaVest Holding LP, one of our sponsors, transferred an aggregate of 1,035,000 founder shares to Peace Capital Limited, our other sponsor. The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination and (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction after our initial business combination that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. As of September 30, 2025 and December 31, 2024, the amounts due to related parties were $ 604,294 and $ 516,883 , respectively, which is expected to be settled upon the consummation of the business combination. Administrative Services Agreement Commencing on the date the Units are first listed on the Nasdaq, the Company has agreed to pay TenX Global Capital LP a total of $ 10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For three months ended September 30, 2025 and 2024, the Company incurred $ 30,000 in fees respectively for these services. For nine months ended September 30, 2025 and 2024, the Company incurred $ 90,000 in fees respectively for these services. Promissory Notes — Related Party On June 3, 2022, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate of $ 150,000 to cover expenses related to the IPO. On April 11, 2024, the Company amended and restated the Promissory Note with AlphaVest Holding LP to extend the maturity date to the earlier of : (i) September 12, 2024 or (ii) promptly after the date of the consummation of the business combination. The Promissory Note expired on September 12, 2024. As of September 30, 2025 and December 31, 2024, $ 0 was outstanding. On December 21, 2023, Alphavest Holding LP, one of the Sponsor, agreed to loan the Company $ 165,000 (as amended and restated, the “Extension Note”) to cover expenses in connection with extensions of Business Combination Period. The Extension Note is unsecured, interest-free and payable on the earlier of: (i) March 22, 2024 or (ii) promptly after the date on which the Company consummates a Business Combination (such earlier date, the “Maturity Date”). The Company may request, from time to time, up to $ 715,000 in drawdowns under this Extension Note to be used for extension payments related to the Company’s Business Combination. Principal of this Extension Note may be drawn down from time to time prior to the Maturity Date upon written request from the Company. On April 15, 2024, the Company amended and restated the Extension Note with AlphaVest Holding LP to increase the principal amount to $ 715,000 extend the maturity date to the earlier of : (i) September 12, 2024 or (ii) promptly after the date of the consummation of the business combination. As of September 30, 2025 and December 31, 2024, $ 220,000 was outstanding. 12 On March 12, 2024, the Company issued a promissory note to TenX Global Capital LP (the “Promissory Note 1”), pursuant to which the Company could borrow up to an aggregate of $ 400,000 . The entire unpaid principal balance of this Note shall be payable on the earlier of: (i) September 12, 2024 (six (6) months from the issuing of this Note) or (ii) promptly after the date on which Maker consummates an initial business combination (a “Business Combination”) (such earlier date, the “Maturity Date”) (as described in its initial public offering prospectus dated December 19, 2022 (the “Prospectus”)). On January 6, 2025, the promissory note was further amended and restated to extend the maturity date to promptly after the date the business combination is consummated. As of September 30, 2025 and December 31, 2024, $ 338,326 and $ 287,046 were outstanding respectively. Website Service On February 22, 2025 and 2024, the Company agreed to pay TenX Global Capital LP for website service. For three months ended September 30, 2025 and 2024, the Company incurred $ 102 and $ 134 in fees for these services, respectively. For nine months ended September 30, 2025 and 2024, the Company incurred $ 511 and $ 425 in fees for these services, respectively. Note 5 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, ordinary shares issued to EBC, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement signed prior to or on the effective date of Proposed Public Offering requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company and EBC signed an engagement letter which was amended on September 15, 2022, pursuant to which, the Company will grant EBC 45-day option from the date of Proposed Public Offering to purchase up to 900,000 additional Units to cover over-allotments, if any, at the Proposed Public Offering price less the underwriting discounts and commissions. On December 29, 2022, EBC fully exercised the over-allotment. EBC was paid a cash underwriting discount of $ 1,725,000 in the aggregate. Business Combination Marketing Agreement The Company has engaged EBC as an advisor in connection with its Business Combination to assist in holding meetings with the Company stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing its securities in connection with its initial Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay EBC a cash fee for such services upon the consummation of its initial business combination in an amount equal to 3.5 % of the gross proceeds of the IPO, or $ 2,415,000 in aggregate. As of September 30, 2025, such fee was incurred as the underwriter had completed substantially all services stated in the marketing agreement. In addition, the Company will pay EBC a cash fee in an amount equal to 1.0 % of the total consideration payable in the initial Business Combination if it introduces the Company to the target business with whom it completes an initial Business Combination. As of the filing date, no such service has been provided by EBC. 13 NOTE 6 – SHAREHOLDERS’ EQUITY Preference Shares — The Company is authorized to issue 2,000,000 preference shares with a par value of $ 0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2025, there were no shares of preference shares issued or outstanding. Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $ 0.0001 per share Holders of ordinary shares are entitled to one vote for each share . On February 7, 2022, the Sponsor received 1,725,000 shares of the Company’s ordinary shares in exchange for $ 25,000 paid for deferred offering costs borne by the Founder. Out of the 1,725,000 ordinary shares, an aggregate of up to 225,000 ordinary shares were subject to forfeiture to the extent that the over-allotment option is not exercised in full or in part so that the number of Founder Shares will equal 20 % of the Company’s issued and outstanding ordinary shares after the Public Offering (excluding Private Shares) On July 11, 2022, EBC received an aggregate of 125,000 ordinary shares (“EBC Founder Shares”) for an aggregate purchase price of $ 1,750 , or approximately $ 0.014 per share. The Company estimated the fair value of the EBC founder shares to be $ 1,812 based upon the price of the founder shares issued to the Sponsor. The holders of the EBC founder shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. On December 22, 2022, the Sponsor and EBC received an aggregate of 390,000 private units ( 365,000 private units purchased by the Sponsor and 25,000 private units purchased by EBC) at a price of $ 10.00 per unit for a total purchase price of $ 3,900,000 in a private placement. On December 29, 2022, as a result of the EBC’s election to fully exercise their over-allotment option, the Sponsor and EBC received additional 40,500 private units on a pro rata basis ( 37,904 private units purchased by the Sponsor and 2,596 private units purchased by EBC) at a price of $ 10.00 per unit. As of September 30, 2025 and December 31, 2024, there were 2,280,500 ordinary shares issued and outstanding, excluding 1,574,356 ordinary shares subject to possible redemption which are presented as temporary equity as of September 30, 2025 and December 31, 2024. Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of one share of ordinary shares upon consummation of a Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law. In the event the Company is not the surviving company upon completion of the Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one ordinary shares underlying each right upon consummation of the Business Combination. If the Company is unable to complete a Business Combination within the required time period and the Company redeems the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless. Note 7 — Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2025 and December 31, 2024. and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. In September 2025, the Company transferred the funds from the trust account to trust escrow account in connection with the upcoming business combination closing, at which point the funds ceased to be invested and therefore reclassified from Level 1 marketable securities to restricted assets held in escrow account. SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Date Trading Securities Level Fair Value September 30, 2025 None December 31, 2024 Marketable securities held in the trust account 1 $ 18,000,701 NOTE 8 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. 14